Search for: "Endo Pharmaceuticals Inc." Results 1 - 20 of 158
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Aug 2022, 11:39 am by Eileen McDermott
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
18 Aug 2022, 11:39 am by Eileen McDermott
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
21 Apr 2022, 3:26 pm by PP&S Team
CVS Health Corp. and CVS Pharmacy Inc. will pay the state $484 million, while Teva Pharmaceuticals Industries Ltd. will pay $195 million, Allergan PLC over $134 million, and Endo Health Solutions $65 million. [read post]
” Upon paying the settlement amount, Endo and two of its subsidiaries, Endo Pharmaceuticals Inc. and Endo Health Solutions Inc., will fully resolve Florida’s pending opioid-related claims. [read post]
16 Dec 2021, 12:15 pm by Simmons Hanly Conroy
She recommended that Teva and its subsidiaries receive 50 percent of liability and Anda, Inc., the other 50 percent. [read post]
7 Nov 2021, 9:31 am by Professor Alberto Bernabe
  The defendants included Johnson & Johnson, Teva Pharmaceutical Industries, Endo International and AbbVie Inc. [read post]
28 Oct 2021, 7:40 am by Simmons Hanly Conroy
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
28 Oct 2021, 7:40 am by Simmons Hanly Conroy
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
21 Oct 2021, 9:50 am by Simmons Hanly Conroy
For more details on any of the previous weeks in the New York opioid trial, visit past coverage: New York Opioid Trial Begins With Opening Arguments “Gremlins” Analogy Nets National Headlines New York Agrees to $1.18 Billion Settlement With Three Major Distributors Local Officials, First Responders Testify in New York Opioid Trial New York State Files Motion for Default Judgment Endo Pharmaceuticals Agrees to Settlement Remaining defendants in the trial include Teva… [read post]
16 Sep 2021, 12:57 pm by Simmons Hanly Conroy
Suffolk and Nassau Counties will each receive $13.85 million in combined settlements from Endo and its subsidiary Par Pharmaceutical, Inc. [read post]
16 Aug 2021, 6:32 am by Robert Kraft
” Furthermore, drugmakers AbbVie, Teva, and Endo are also missing from the settlement even though they “have been accused of misleadingly marketing their pain medicines as safe. [read post]
10 Aug 2021, 6:20 am by Robert Kraft
” With the “settlements, only three drug manufacturers, Endo Health Solutions, Teva Pharmaceuticals USA and Allergan Finance, remain at trial. [read post]
30 Jul 2021, 7:01 am by Simmons Hanly Conroy
The New York State opioid trial continues against three major drugmakers, Endo International Plc., Teva Pharmaceutical Industries Ltd., and AbbVie Inc’s Allergan unit, which all stand accused of having deceptively marketed their opioid painkillers. [read post]